(Q46005434)

English

Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1111/j.1743-6109.2009.01235.x

https://retractionwatch.com/?s=Mohammad+Safarinejad

Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

1 reference

based on heuristic

inferred from title

Peyronie's disease

1 reference

based on heuristic

inferred from title

Mohammad Reza Safarinejad

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

publication date

23 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

number of pages

12

1 reference

based on heuristic

inferred from page(s)

The Journal of Sexual Medicine

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

1743-1754

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Electron microscopic study of the penile plaques and adjacent corpora cavernosa in Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Peyronie's disease: etiology, epidemiology and medical treatment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Peyronie's disease (CME).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Primary prevention of cardiovascular disease: a call to action

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Peyronie's disease: a review

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Vascular abnormalities in Peyronie's disease: the role of color Doppler sonography.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Diet and rheumatoid arthritis: a review of the literature

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

A critical analysis of nonsurgical treatment of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The natural history of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Intralesional verapamil prevents the progression of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Procarbazine (Natulan) in the treatment of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The natural history of Peyronie's disease: an ultrasonography-based study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Omega-3 fatty acids in inflammation and autoimmune diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The chronology of depression and distress in men with Peyronie's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

An analysis of the natural history of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Pathophysiology of Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Dietary polyunsaturated fatty acids and inflammatory mediator production

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Expanding the paradigm for plaque development in Peyronie's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Tamoxifen versus placebo in the treatment of Peyronie's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Colour Doppler ultrasound of the penis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Classification of congenital and acquired penile deviation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1743-6109.2009.01235.X

Identifiers

10.1111/J.1743-6109.2009.01235.X

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19453924

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46005434&oldid=2042020674"